Pharmaceutical Supply of Atropine Sulfate Injection

This contract entails the supply and delivery of 4,000 units of Atropine Sulfate Injection, USP, a critical medication used in emergency and military medical scenarios. The contract specifies stringent requirements for the shelf-life and packaging of the product to ensure its efficacy and safety during storage and use. The procurement is conducted as a subcontract under the Department of Defense's Medical Supply Chain Pharmacy FSA, reflecting its strategic importance in supporting medical readiness. The solicitation was posted on May 28, 2026, with responses due by June 3, 2026. The work falls under the NAICS code 325412, which pertains to pharmaceutical preparation manufacturing. Although specific location details for performance and points of contact are not provided, the focus remains on timely fulfillment to maintain critical stock levels for defense-related medical needs. The contract underscores the emphasis on quality and reliability in the supply of essential pharmaceutical countermeasures.